Otalgia Medication

  • Author: John C Li, MD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Mar 6, 2012
 

Medication Summary

Use antibiotics in treating various types of infections (eg, tonsillitis, pharyngitis, sinusitis). Use antivirals if the causative agent is suspected to be viral such as in cases associated with herpes zoster or shingles. Antifungals are indicated if the source is caused by a fungus (eg, oral thrush/candidiasis). Antiulcer/antacid medications can be used for esophagitis or gastroesophageal reflux disease. Use NSAIDs when myalgias and neuralgias are suspected. Reexamine the patient after a 2-week trial of NSAIDs.

Perform a detailed search for the underlying diagnosis before initiating treatment. Starting analgesics before reaching a diagnosis increases the difficulty of determining the cause and may possibly obscure a life-threatening condition such as an occult cancer.

Any of the previously mentioned treatments can be implemented when the exact cause of referred otalgia is suspected. If the problem persists after a 2- to 3-week trial, a more advanced algorithm is indicated.

Next

Antibiotics

Class Summary

Therapy must be comprehensive and cover all likely pathogens in the context of this clinical setting. Resort to empiric antimicrobial therapy only after an exhaustive search for a source of pain has failed.

Amoxicillin and clavulanate (Augmentin)

 

Treats bacteria resistant to beta-lactam antibiotics.

Amoxicillin (Amoxil, Trimox)

 

Interferes with synthesis of cell wall mucopeptides during active multiplication, resulting in bactericidal activity against susceptible bacteria.

Clarithromycin (Biaxin)

 

Inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes causing cessation of RNA-dependent protein synthesis.

Ciprofloxacin (Cipro)

 

Fluoroquinolone with activity against pseudomonads, streptococci, MRSA, Staphylococcus epidermidis, and most gram-negative organisms, but no activity against anaerobes. Inhibits bacterial DNA synthesis, and consequently, growth.

Previous
Next

Antivirals

Class Summary

Nucleoside analogs are initially phosphorylated by viral thymidine kinase to eventually form a nucleoside triphosphate.

Acyclovir (Zovirax)

 

Has demonstrated inhibitory activity against both HSV-1 and HSV-2. Selectively incorporated into infected cells.

Famciclovir (Famvir)

 

Prodrug that when biotransformed into active metabolite, penciclovir, may inhibit viral DNA synthesis/replication.

Valacyclovir (Valtrex)

 

Prodrug rapidly converted to the active drug acyclovir. More expensive but has a more convenient dosing regimen than acyclovir.

Previous
Next

Antifungals

Class Summary

Mechanism of action may involve an alteration of RNA and DNA metabolism or an intracellular accumulation of peroxide that is toxic to the fungal cell.

Fluconazole (Diflucan)

 

Synthetic PO antifungal (broad-spectrum bistriazole) that selectively inhibits fungal cytochrome P-450 and sterol C-14 alpha-demethylation.

Nystatin (Mycostatin)

 

Fungicidal and fungistatic antibiotic obtained from Streptomyces noursei. Effective against various yeasts and yeastlike fungi. Changes permeability of fungal cell membrane after binding to cell membrane sterols, causing cellular contents to leak.

Previous
Next

Antacids

Class Summary

These agents can be used for esophagitis or gastroesophageal reflux disease.

Famotidine (Pepcid)

 

Competitively inhibits histamine at H2 receptor of gastric parietal cells, resulting in reduced gastric acid secretion, gastric volume, and reduced hydrogen concentrations.

Ranitidine (Zantac)

 

Inhibits histamine stimulation of the H2 receptor in gastric parietal cells, which reduces gastric acid secretion, gastric volume, and hydrogen concentrations.

Lansoprazole (Prevacid)

 

Inhibits gastric acid secretion.

Omeprazole (Prilosec)

 

Inhibit gastric acid secretion by inhibiting H+/K+ ATPase enzyme system at secretory surface of gastric parietal cells.

Esomeprazole magnesium (Nexium)

 

S-isomer of omeprazole. Inhibits gastric acid secretion by inhibiting H+/K+ -ATPase enzyme system at secretory surface of gastric parietal cells.

Used in severe cases of and patients not responding to H2 antagonist therapy.

Used for up to 4 wk to treat and relieve symptoms of active duodenal ulcers; may be used up to 8 wk to treat all grades of erosive esophagitis.

Previous
Next

Analgesics

Class Summary

Pain control is essential to quality patient care.

Ibuprofen (Motrin, Advil)

 

DOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.

Hydrocodone and acetaminophen (Lortab, Vicodin)

 

Drug combinations indicated for moderate to severe pain.

Oxycodone and acetaminophen (Percocet)

 

Drug combination indicated for the relief of moderate to severe pain.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

John C Li, MD  Private Practice in Otology and Neurotology; Medical Director, Balance Center

John C Li, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Tinnitus Association, Florida Medical Association, and North American Skull Base Society

Disclosure: Nothing to disclose.

Coauthor(s)

Jared Brunk, PA-C  Physician Assistant Certified, Office of John Li, MD

Disclosure: Nothing to disclose.

Specialty Editor Board

Michael E Hoffer, MD  Director, Spatial Orientation Center, Department of Otolaryngology, Naval Medical Center of San Diego

Michael E Hoffer, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: American biloogical group Royalty Other

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Peter S Roland, MD  Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Alcon Labs Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear Corp Honoraria Board membership; Med El Corp travel grants Consulting; Foresight Consulting fee Consulting

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Medvoy Ownership interest Management position; Cerescan Imaging Consulting; Headwatersmb Consulting fee Consulting; Venturequest Royalty Consulting

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthor Thomas Ulrich, PA, to the development and writing of this article.

References
  1. Adour KK. Acute temporomandibular joint pain-dysfunction syndrome: neuro-otologic and electromyographic study. Am J Otolaryngol. May 1981;2(2):114-22. [Medline].

  2. Al-Sheikhli AR. Pain in the ear--with special reference to referred pain. J Laryngol Otol. Dec 1980;94(12):1433-40. [Medline].

  3. Frankel VH. Whiplash injuries to the neck. In: Hirsch C, Zotterman Y, eds. Cervical Pain. New York, NY: Pergamon Press; 1971.

  4. Gibson WS Jr, Cochran W. Otalgia in infants and children--a manifestation of gastroesophageal reflux. Int J Pediatr Otorhinolaryngol. 1994;Jan;28(2-3):213-8.

  5. Goethals PL. Referred otalgia. JFMA. Jun 1972;59(6):26-30. [Medline].

  6. Kreisberg MK, Turner J. Dental causes of referred otalgia. Ear Nose Throat J. Oct 1987;66(10):398-408. [Medline].

  7. Kuttila S, Kuttila M, Le Bell Y. Characteristics of subjects with secondary otalgia. J Orofac Pain. Summer 2004;18(3):226-34.

  8. Malik MK, Sharma JK. Referred otalgia of dental origin. J Indian Dent Assoc. Oct 1975;47(10):413-6. [Medline].

  9. Olsen KD. The many causes of otalgia. Infection, trauma, cancer. Postgrad Med. Nov 1 1986;80(6):50-2, 55-6, 61-3. [Medline].

  10. Sataloff RT, Price DB. Distention of the stylomandibular ligament as a cause of styloid pain syndrome. Ear Nose Throat J. Sep 1984;63(9):412-5. [Medline].

  11. Scarbrough TJ, Day TA, Williams TE. Referred otalgia in head and neck cancer: a unifying schema. Am J Clin Oncol. 2003;Oct;26(5):e157-62.

  12. Shah RK, Blevins NH. Otalgia. Otolaryngol Clin North Am. Dec 2003;36(6):1137-51. [Medline].

  13. Subramaniam S, Majid MD. Eagle's syndrome. Med J Malaysia. Mar 2003;58(1):139-41. [Medline].

  14. Thaller SR, De Silva A. Otalgia with a normal ear. Am Fam Physician. Oct 1987;36(4):129-36. [Medline].

  15. Travell JG, Simons DG. Myofascial pain and dysfunction. In: The Trigger Point Manual. Baltimore, Md: Lippincott Williams & Wilkins; 1983.

  16. Wazen JJ. Referred otalgia. Otolaryngol Clin North Am. Dec 1989;22(6):1205-15. [Medline].

  17. Williamson EH. The interrelationship of internal derangements of the temporomandibular joint, headache, vertigo, and tinnitus: a survey of 25 patients. Facial Orthop Temporomandibular Arthrol. Jan 1986;3(1):13-7. [Medline].

  18. Yules RB. Differential diagnosis of referred otalgia. Eye Ear Nose Throat Mon. May 1967;46(5):587-8. [Medline].

Previous
Next
 
This picture demonstrates the diversity of pathologies that can be the source of referred otalgia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.